Monday, September 22, 2025

No Result

View All Result

Home
Tech & Software
Earnings
Analysis
Trading & Momentum
Cryptocurrency
Banking & Insurance
AI & Quantum Computing

No Result

View All Result

No Result

View All Result

Home Tag PRME

Tag: PRME

Guggenheim Analyst Reiterates Buy Rating on Prime Medicine with Revised Price Target

by Elaine Mendonca

March 5, 2024

Guggenheim analyst Debjit Chattopadhyay has reiterated his Buy rating on Prime Medicine (NASDAQ: PRME) on March 5, 2024, while adjusting ...

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Tag: PRME

Guggenheim Analyst Reiterates Buy Rating on Prime Medicine with Revised Price Target

Don't Miss It

H.B. Fuller Q3 Earnings Release Sets Stage for Pivotal Investor Week

Covered Call Strategy Faces Test Amid Tech Sector Volatility

Cardano at a Critical Juncture: Whale Activity and Ecosystem Growth Face Off Against Market Pressure

Categories

Popular News

Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations

Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize

Kraft Heinz Stock: A Contradiction in Market Sentiment

NextGen Healthcare Charts Course for Behavioral Health Transformation

Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies

Recommended

Defense Sector Momentum Could Propel Deutz AG’s Strategic Growth

Valneva Shares Face Regulatory Setback Despite Promising Pipeline

Strategic Naval Acquisition Positions Rheinmetall for Broader Defense Dominance

Berkshire Hathaway Concludes 17-Year BYD Investment with Complete Exit

Analysts Defend SAP’s Market Position Against Oracle Competition

Recent News

Category

Tag: PRME

Don't Miss It

Categories

Browse by Tag

Popular News

Recommended

Recent News

Category